The global liquid biopsy sector is seeing significant growth, driven by progress in cancer diagnosis and targeted medicine. Current assessments position the market size at around USD X.X billion in 2023, with forecasts pointing to a a anticipated annual growth rate of Y% through 2032. Dominant trends encompass the rising usage of minimal residual d